Skip to main navigation
Oric Logo Oric Logo OricPharma logo
  • About
    • Overview
    • Leadership Team
    • Board of Directors
    • Founders
    • Contact
  • Pipeline
    • Overview
    • ORIC-533
    • ORIC-114
    • ORIC-944
    • PLK4
    • Publications
  • Patients
    • Overview
    • Clinical Trials
  • Investors & News
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
    • Analyst Coverage
    • Corporate Governance
    • SEC Filings
    • Quarterly Results
    • Investor FAQs
    • Contact IR
  • Careers
    • Overview
    • Culture & Values
    • Benefits
    • Current Openings
CONTACT US
info@oricpharma.com
(650) 388-5600
 
Scientist in lab

Press Releases

Press Releases

June 2, 2023
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 31, 2023
ORIC Pharmaceuticals to Participate in the Jefferies Healthcare Conference
May 8, 2023
ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
May 5, 2023
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 25, 2023
ORIC Pharmaceuticals to Participate in the H.C. Wainwright BioConnect Investor Conference
April 18, 2023
ORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual Meeting
March 16, 2023
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates
March 14, 2023
ORIC Pharmaceuticals Announces Multiple Presentations at the 2023 American Association for Cancer Research (AACR) Annual Meeting
March 6, 2023
ORIC Pharmaceuticals to Participate in the Oppenheimer 33rd Annual Healthcare Conference
February 3, 2023
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 13
Print PRINT
Email Page EMAIL PAGE
Contact IR Contact IR
RSS RSS
Email Alerts Email Alerts
Contact
info@oricpharma.com
(650) 388-5600
 
  • Home
  • Pipeline
  • Investors & News
  • Privacy Policy
  • About
  • Patients
  • Careers
  • Terms of Use
©2023 ORIC Pharmaceuticals, Inc. All rights reserved.